CDMO Leadership Awards 2023


Hamburg, Germany, 23 March 2023:
Evotec announces that the Company has been selected as a winner of a 2023 CDMO Leadership Award across all the six core categories included in the award program including Capabilities, Compatibility, Expertise, Quality, Reliability and Service across two groups of respondents, Small Pharma, and Overall (combined Big and Small Pharma).

The awards are presented by Life Science Leader and Outsourced Pharma and the research is conducted by ISR Reports’ Contract Manufacturing Quality Benchmarking annual online surveys. For the 2023 CDMO Leadership Awards, 72 CDMOs were evaluated on 23 performance metrics. 

Research participants were recruited from biopharmaceutical companies of all sizes and were screened for decision-making influence and authority when it comes to working with contract manufacturing suppliers. Respondents only evaluated companies with which they have worked on an outsourced project in the past 18 months.

“Congratulations to the 2023 CDMO Leadership Award winners. You served our industry – and patients around the world – through some turbulent and unsettled times and rose above all others in meeting supply-chain and innovation challenges, and effectively advancing new platforms, technologies, and products. An award in any category – capabilities, compatibility, expertise, quality, reliability, and service – is one you and all your customers should be proud of,” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma

To learn more about the CDMO Leadership Awards, please follow this link.